Structure-based modeling of the functional HIV-1 intasome and its inhibition
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The intasome is the basic recombination unit of retroviral integration, comprising the integrase protein and the ends of the viral DNA made by reverse transcription. Clinical inhibitors preferentially target the DNA-bound form of integrase as compared with the free protein, highlighting the critical requirement for detailed understanding of HIV-1 intasome structure and function. Although previous biochemical studies identified integrase residues that contact the DNA, structural details of protein–protein and protein–DNA interactions within the functional intasome were lacking. The recent crystal structure of the prototype foamy virus (PFV) integrase–viral DNA complex revealed numerous details of this related integration machine. Structures of drug-bound PFV intasomes moreover elucidated the mechanism of inhibitor action. Herein we present a model for the HIV-1 intasome assembled using the PFV structure as template. Our results pinpoint previously identified protein–DNA contacts within the quaternary structure and reveal hitherto unknown roles for Arg20 and Lys266 in DNA binding and integrase function. Models for clinical inhibitors bound at the HIV-1 integrase active site were also constructed and compared with previous studies. Our findings highlight the structural basis for HIV-1 integration and define the mechanism of its inhibition, which should help in formulating new drugs to inhibit viruses resistant to first-in-class compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R. (1994) · Science · doi:10.1126/science.7801124 · Cited by 810 · cited 1×
“Because 5 bp, roughly equivalent to 18 Å in ideal B-form DNA, separates the points of attack on target DNA phosphodiesters during strand transfer, it was unlikely that this pair of active sites catalyzed the integration of both viral DNA ends (2).”
BackgroundSelf-citationRetroviral intasome assembly and inhibition of DNA strand transfer
Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature08784 · Cited by 678 · cited 10×
“As observed in the PFV structure (26), the majority of HIV-1 IN residues contact the nontransferred DNA strand (Table S1).”
BackgroundInfluentialSelf-citationNowotny, M., Gaidamakov, S. A., Crouch, R. J., & Yang, W. (2005) · Cell · doi:10.1016/j.cell.2005.04.024 · Cited by 620 · cited 1×
“Consistent with a two metal ion reaction mechanism (26, 37), two Mn ions (Fig.”
BackgroundChen, J. C.-H., Krucinski, J., Miercke, L. J. W., Finer-Moore, J. S., Tang, A. H., Leavitt, A. D., & Stroud, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150220297 · Cited by 404 · cited 11×
“The previous two-domain NTD-CCD (14) and CCD-CTD (15) crystal structures have been widely used Author contributions: L.K., X.L., P.C., and A.E. designed research; L.K., X.L., H.L.N., P.C., and A.E. performed research; L.K., X.L., H.L.N., P.C., and A.E. analyzed data; and L.K., S.H., P.C., and A.E. wrote the paper.”
BackgroundMethodResultInfluentialGrobler, J. A., Stillmock, K., Hu, B., Witmer, M., Felock, P., Espeseth, A. S., Wolfe, A., Egbertson, M., Bourgeois, M., Melamed, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092056199 · Cited by 399 · cited 2×
“The underlying features of the drugs, coplanar oxygen atoms and aromatic rings that tend to be halogenated (12, 13, 42), had suggested that coordination of critical divalent metal ions via pharmacophore oxygens underscores the mechanism of inhibition (38), and our results indeed highlight these interactions between RA…”
BackgroundEspeseth, A. S., Felock, P., Wolfe, A., Witmer, M., Grobler, J., Anthony, N., Egbertson, M., Melamed, J. Y., Young, S., Hamill, T., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200139397 · Cited by 317 · cited 2×
“Because INSTIs preferentially bind to and inhibit the IN–DNAcomplex as comparedwith free IN(16), the elusive 3D structure would predictably play an important role in developing second-generation INSTIs to inhibit viruses resistant to front-line compounds.”
BackgroundRichardson, J. M., Colloms, S. D., Finnegan, D. J., & Walkinshaw, M. D. (2009) · Cell · doi:10.1016/j.cell.2009.07.012 · Cited by 145 · cited 2×
“A theme common to transpososome (3, 4) and retroviral intasome (26) structures is the unpairing of the donor DNA duplex at the enzyme active site, which is probably important to unveil the scissile phosphodiester bond for 3′ processing and resulting 3′-OH nucleophile for subsequent DNA strand transfer.”
BackgroundFunctional and structural characterization of the integrase from the prototype foamy virus
Valkov, E., Gupta, S. S., Hare, S., Helander, A., Roversi, P., McClure, M., & Cherepanov, P. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn938 · Cited by 130 · cited 9×
“PFV intasome activity, as well as cell infection by PFV, is inhibited by RAL and EVG (41).”
BackgroundInfluentialSelf-citationStructural Basis for Functional Tetramerization of Lentiviral Integrase
Hare, S., Di Nunzio, F., Labeja, A., Wang, J., Engelman, A., & Cherepanov, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000515 · Cited by 122 · cited 6×
“The results of some experiments have indicated that an HIV-1 IN dimer can suffice to process a DNA end (52, 53), whereas we and others have concluded that processing is likely to occur within the context of the tetramer (8, 19, 54).”
BackgroundInfluentialSelf-citationChen, H., Wei, S.-Q., & Engelman, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17358 · Cited by 103 · cited 1×
“The integration activity of PICs extracted from infected cells persistswhen the complexes are treatedwithhigh salt (5, 6), and the term “intasome” was coined to describe the PIC substructure that catalyzes integration in vitro (6, 7).”
Self-citationA large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration
Wei, S., Mizuuchi, K., & Craigie, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7511 · Cited by 102
Langley, D. R., Samanta, H. K., Lin, Z., Walker, M. A., Krystal, M. R., & Dicker, I. B. (2008) · Biochemistry · doi:10.1021/bi801372d · Cited by 42 · cited 15×
“The mechanism of INSTIIN binding has been difficult to ascertain in the absence of intasome structural information.”
BackgroundResultInfluential
Cited by
Craigie, R., & Bushman, F. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006890 · Cited by 327
Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010246107 · Cited by 305
“However, due to the high level of conservation between retroviral INs, in particular within their active sites (6, 8, 9, 17), PFV IN can serve as a convenient proxy for structural studies of HIV INSTIs (18, 19).”
BackgroundSelf-citationThe mechanism of retroviral integration from X-ray structures of its key intermediates
Maertens, G. N., Hare, S., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature09517 · Cited by 296
Self-citationHare, S., Smith, S. J., Métifiot, M., Jaxa-Chamiec, A., Pommier, Y., Hughes, S. H., & Cherepanov, P. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073189 · Cited by 264
Self-citationInterfacial inhibitors: targeting macromolecular complexes
Pommier, Y., & Marchand, C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3404 · Cited by 259
Metadata
- Authors
- Krishnan, L., Li, X., Naraharisetty, H. L., Hare, S., Cherepanov, P., & Engelman, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-08-23
- Volume
- 107
- Issue
- 36
- Pages
- 15910-15915
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2044660041
- Cited by
- 191
- References
- 12
- FWCI
- 18.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.